| Literature DB >> 34813382 |
Luigi Angelo Vaira1,2, Giovanni Salzano1,3, Serge Daniel Le Bon4, Angelantonio Maglio5, Marzia Petrocelli6, Younes Steffens4, Enrica Ligas1, Fabio Maglitto1,3, Jerome R Lechien7,8, Sven Saussez8, Alessandro Vatrella5, Francesco Antonio Salzano9, Paolo Boscolo-Rizzo10, Claire Hopkins11, Giacomo De Riu1,2.
Abstract
The purpose of this multicenter case-control study was to evaluate a group of patients at least 1 year after coronavirus disease 2019 (COVID-19) with Sniffin' Sticks tests and to compare the results with a control population to quantify the potential bias introduced by the underlying prevalence of olfactory dysfunction (OD) in the general population. The study included 170 cases and 170 controls. In the COVID-19 group, 26.5% of cases had OD (anosmia in 4.7%, hyposmia in 21.8%) versus 3.5% in the control group (6 cases of hyposmia). The TDI score (threshold, discrimination, and identification) in the COVID-19 group was significantly lower than in the control group (32.5 [interquartile range, 29-36.5] vs 36.75 [34-39.5], P < .001). The prevalence of OD was significantly higher in the COVID-19 group, confirming that this result is not due to the underlying prevalence of OD in the general population.Entities:
Keywords: COVID-19; PS/QI; SARS-CoV-2; anosmia; coronavirus; long COVID-19; olfactory; prospective study; smell
Mesh:
Year: 2021 PMID: 34813382 DOI: 10.1177/01945998211061511
Source DB: PubMed Journal: Otolaryngol Head Neck Surg ISSN: 0194-5998 Impact factor: 5.591